» Articles » PMID: 39588328

Case Report: A Finding of PVOD and PAH in First Degree Relatives Suggests Shared Heritable Risk and Overlapping Features of Both Pulmonary Vascular Diseases

Overview
Date 2024 Nov 26
PMID 39588328
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary vascular disease that is difficult to distinguish clinically from pulmonary arterial hypertension (PAH). Multiple genes have been implicated in disease pathogenesis in PAH and PVOD and the diseases are thought to be genetically distinct. In this report we present a case of first-degree relatives with pathological evidence of PVOD and PAH. The index patient was diagnosed with PAH at age 42, was treated with escalating pulmonary vasodilator therapy, but eventually succumbed to her disease. On autopsy, her pathology was consistent with PAH. Her son was diagnosed with PAH at age 16, did well on pulmonary vasodilator therapy for over 10 years, but ultimately developed refractory right ventricular failure and received a heart and lung transplantation. Pathology of his explanted lung was consistent with PVOD, and genetic testing was negative for recognized variants that cause PAH or PVOD.

Citing Articles

Case report: A finding of PVOD and PAH in first degree relatives suggests shared heritable risk and overlapping features of both pulmonary vascular diseases.

Winters R, Forbes L, Ivy D, Cool C, Park B, Hountras P Respirol Case Rep. 2024; 12(11):e70064.

PMID: 39588328 PMC: 11588353. DOI: 10.1002/rcr2.70064.

References
1.
Pietra G, Capron F, Stewart S, Leone O, Humbert M, Robbins I . Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004; 43(12 Suppl S):25S-32S. DOI: 10.1016/j.jacc.2004.02.033. View

2.
Eichstaedt C, Belge C, Chung W, Graf S, Grunig E, Montani D . Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH. Eur Respir J. 2022; 61(2). PMC: 9947314. DOI: 10.1183/13993003.01471-2022. View

3.
Winters R, Forbes L, Ivy D, Cool C, Park B, Hountras P . Case report: A finding of PVOD and PAH in first degree relatives suggests shared heritable risk and overlapping features of both pulmonary vascular diseases. Respirol Case Rep. 2024; 12(11):e70064. PMC: 11588353. DOI: 10.1002/rcr2.70064. View

4.
Ghigna M, Guignabert C, Montani D, Girerd B, Jais X, Savale L . BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension. Eur Respir J. 2016; 48(6):1668-1681. DOI: 10.1183/13993003.00464-2016. View

5.
Humbert M, Guignabert C, Bonnet S, Dorfmuller P, Klinger J, Nicolls M . Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2018; 53(1). PMC: 6351340. DOI: 10.1183/13993003.01887-2018. View